Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: Extending the Indication for resection?

Surgery (United States)

Volumn 152, Issue 5, 2012, Pages 809-820

  Chang, Wen Tsan ^a,b,c   Kao, Wei Yu ^c   Chau, Gar Yang ^c,d   Su, Chien Wei ^c,d   Lei, Hao Jan ^c,d   Wu, Jaw Ching ^c,d   Hsia, Cheng Yuan ^c,d   Lui, Wing Yiu ^d,e   King, Kuang Liang ^c,d   Lee, Shou Dong ^d,f  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INDOCYANINE GREEN; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT INDICATION; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84867573392     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2012.03.024     Document Type: Article

References (49)

1. M. Omata, L.A. Lesmana, R. Tateishi, P.J. Chen, S.M. Lin, and H. Yoshida Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
2. P. Ferenci, M. Fried, D. Labrecque, J. Bruix, M. Sherman, and M. Omata Hepatocellular carcinoma (HCC): a global perspective J Clin Gastroenterol 44 2010 239 245
3. J.M. Llovet, and J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 Suppl 1 2008 S20 S37
4. W.Y. Kao, Y.Y. Chiou, H.H. Hung, Y.H. Chou, C.W. Su, and J.C. Wu Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase- platelet ratio index Eur J Gastroenterol Hepatol 23 2011 528 536
5. C.H. Chang, G.Y. Chau, W.Y. Lui, S.H. Tsay, K.L. King, and C.W. Wu Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver Arch Surg 139 2004 320 325
6. H.J. Lei, G.Y. Chau, W.Y. Lui, S.H. Tsay, K.L. King, and C.C. Loong Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma J Am Coll Surg 203 2006 426 435
7. H.H. Hung, Y.Y. Chiou, C.Y. Hsia, C.W. Su, Y.H. Chou, and J.H. Chiang Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas Clin Gastroenterol Hepatol 9 2011 79 86
8. W.Y. Kao, C.W. Su, G.Y. Chau, W.Y. Lui, C.W. Wu, and J.C. Wu A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery World J Surg 35 2011 858 867
9. B. Guiu, A. Minello, V. Cottet, C. Lepage, P. Hillon, and J. Faivre A 30-year, population-based study shows improved management and prognosis of hepatocellular carcinoma Clin Gastroenterol Hepatol 8 2010 986 991
10. T.I. Huo, H.C. Lin, C.Y. Hsia, J.C. Wu, P.C. Lee, and C.W. Chi The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey Am J Gastroenterol 102 2007 1920 1930
11. A. Grieco, M. Pompili, G. Caminiti, L. Miele, M. Covino, and B. Alfei Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre Gut 54 2005 411 418
12. J.H. Wang, C.S. Changchien, T.H. Hu, C.M. Lee, K.M. Kee, and C.Y. Lin The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients Eur J Cancer 44 2008 1000 1006
13. U. Cillo, A. Vitale, F. Grigoletto, F. Farinati, A. Brolese, and G. Zanus Prospective validation of the Barcelona Clinic Liver Cancer staging system J Hepatol 44 2006 723 731
14. G. Torzilli, M. Donadon, M. Marconi, A. Palmisano, D. Del Fabbro, and A. Spinelli Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis Arch Surg 143 2008 1082 1090
15. C.T. Lin, K.F. Hsu, T.W. Chen, J.C. Yu, D.C. Chan, and C.Y. Yu Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg 34 2010 2155 2161
16. T. Ishizawa, K. Hasegawa, T. Aoki, M. Takahashi, Y. Inoue, and K. Sano Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 2008 1908 1916
17. K.K. Ng, J.N. Vauthey, T.M. Pawlik, G.Y. Lauwers, J.M. Regimbeau, and J. Belghiti Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database Ann Surg Oncol 12 2005 364 373
18. W.Y. Lui, G.Y. Chau, C.C. Loong, S.H. Tsay, J.C. Wu, and K.L. King Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma Arch Surg 130 1995 1090 1097
19. H.H. Hung, C.W. Su, C.R. Lai, G.Y. Chau, C.C. Chan, and Y.H. Huang Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma Hepatol Int 4 2010 691 699
20. H.A. Edmondson, and P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
21. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
22. J. Bruix, and J.M. Llovet Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 2002 519 524
23. A. Forner, M.E. Reig, C.R. de Lope, and J. Bruix Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 2010 61 74
24. J. Bruix, M. Sherman, J.M. Llovet, M. Beaugrand, R. Lencioni, and A.K. Burroughs Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
25. I. Ikai, E. Hatano, S. Hasegawa, H. Fujii, K. Taura, and N. Uyama Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein J Am Coll Surg 202 2006 431 438
26. Y.P. Le Treut, J. Hardwigsen, P. Ananian, J. Saisse, E. Gregoire, and H. Richa Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series J Gastrointest Surg 10 2006 855 862
27. G.Y. Chau, W.Y. Lui, and C.W. Wu Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma Surg Oncol Clin N Am 12 2003 25 34
28. S. Eguchi, M. Takatsuki, M. Hidaka, A. Soyama, T. Tomonaga, and I. Muraoka Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection World J Surg 34 2010 1034 1038
29. S. Roayaie, I.N. Blume, S.N. Thung, M. Guido, M.I. Fiel, and S. Hiotis A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma Gastroenterology 137 2009 850 855
30. Y. Xia, Y. Qiu, J. Li, L. Shi, K. Wang, and T. Xi Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial Ann Surg Oncol 17 2010 3137 3144
31. A. Tan, F. Aucejo, and R. Kim Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma? Oncology 78 2010 161 171
32. C.C. Wu, S.R. Hsieh, J.T. Chen, W.L. Ho, M.C. Lin, and D.C. Yeh An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation Arch Surg 135 2000 1273 1279
33. T. Ohkubo, J. Yamamoto, Y. Sugawara, K. Shimada, S. Yamasaki, and M. Makuuchi Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis J Am Coll Surg 191 2000 657 660
34. H. Nathan, R.D. Schulick, M.A. Choti, and T.M. Pawlik Predictors of survival after resection of early hepatocellular carcinoma Ann Surg 249 2009 799 805
35. J.C. Wu, Y.H. Huang, G.Y. Chau, C.W. Su, C.R. Lai, and P.C. Lee Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma J Hepatol 51 2009 890 897
36. T.C. Chua, W. Liauw, A. Saxena, F. Chu, D. Glenn, and A. Chai Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma Liver Int 30 2010 166 174
37. W.P. Zhou, E.C. Lai, A.J. Li, S.Y. Fu, J.P. Zhou, and Z.Y. Pan A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma Ann Surg 249 2009 195 202
38. T. Oikawa, H. Ojima, S. Yamasaki, T. Takayama, S. Hirohashi, and M. Sakamoto Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules J Hepatol 42 2005 225 229
39. W.T. Chen, G.Y. Chau, W.Y. Lui, S.H. Tsay, K.L. King, and C.C. Loong Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome Eur J Surg Oncol 30 2004 414 420
40. M.C. Ho, G.T. Huang, Y.M. Tsang, P.H. Lee, D.S. Chen, and J.C. Sheu Liver resection improves the survival of patients with multiple hepatocellular carcinomas Ann Surg Oncol 16 2009 848 855
41. P.A. Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gores, B. Langer, and A. Perrier Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
42. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
43. M. Ravaioli, G.L. Grazi, F. Piscaglia, F. Trevisani, M. Cescon, and G. Ercolani Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2008 2547 2557
44. F.Y. Yao, R.K. Kerlan Jr., R. Hirose, T.J. Davern 3rd, N.M. Bass, and S. Feng Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
45. H.L. Fan, T.W. Chen, C.B. Hsieh, H.C. Jan, S.C. His, and C. De-Chuan Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria Am J Surg 200 2010 252 257
46. M.E. Facciuto, B. Koneru, J.P. Rocca, D.C. Wolf, L. Kim-Schluger, and P. Visintainer Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation Ann Surg Oncol 15 2008 1383 1391
47. P.E. Majno, F.P. Sarasin, G. Mentha, and A. Hadengue Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis Hepatology 31 2000 899 906
48. D. Fuks, S. Dokmak, V. Paradis, M. Diouf, F. Durand, and J. Belghiti Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis Hepatology 55 2012 132 140
49. R. Kim, M. Fujiki, and F. Aucejo General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option? Liver Int 31 2011 755 763